Burning Rock Biotech Limited (BNR) — Financial statements
Income statement, balance sheet, and cash flow for Burning Rock Biotech Limited — annual and quarterly history with growth and margin analysis.
| Metric (CNY Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 525↑1.8% | 516↓4.0% | 537↓4.6% | 563↑10.9% | 508 | |
| Cost of Revenue | 133↓13.4% | 153↓11.9% | 174↓4.9% | 183↑27.5% | 144 | |
| Gross Profit | 392↑8.2% | 362↓0.2% | 363↓4.4% | 380↑4.4% | 364 | |
| Operating Expenses | ||||||
| R&D Expenses | 162↓30.3% | 232↓33.1% | 347↓17.7% | 422↑14.7% | 368 | |
| General & Administrative Expenses | 0.00↓100.0% | 262↓40.2% | 438↓23.0% | 568↑15.9% | 490 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 191↓22.9% | 248↓33.1% | 370↑22.2% | 303 | |
| SG&A Expenses | 283↓37.4% | 453↓34.0% | 686↓27.0% | 939↑18.3% | 793 | |
| Other Expenses | 0.00↓100.0% | 35 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 445↓38.2% | 720↓30.3% | 1,033↓24.1% | 1,360↑17.2% | 1,161 | |
| Total Costs & Expenses | 578↓33.8% | 873↓27.6% | 1,207↓21.8% | 1,544↑18.3% | 1,305 | |
| Operating Results | ||||||
| Operating Income | -53↑85.1% | -358↑46.6% | -669↑31.7% | -980↓23.0% | -797 | |
| Depreciation & Amortization | 10↓80.3% | 52↓60.9% | 133↑7.5% | 124↑159.8% | 48 | |
| EBITDA | -43↑84.1% | -270↑47.8% | -518↑39.5% | -856↓14.7% | -746 | |
| EBIT | -53↑83.5% | -322↑50.5% | -651↑33.6% | -980↓23.4% | -794 | |
| Interest & Other Income | ||||||
| Net Interest Income | 8↓36.1% | 12↓32.0% | 18↑89.8% | 9↑392.3% | 2 | |
| Interest Income | 8↓35.9% | 12↓32.0% | 18↑89.8% | 9↑173.6% | 3 | |
| Interest Expense | 0.03 | 0.00 | 0.00 | 0.00↓100.0% | 2 | |
| Non-Operating Income | 0.00↑100.0% | -35↓94.9% | -18 | 0.00↑100.0% | -3 | |
| Other Income / Expenses | 1↓93.9% | 17↓6.7% | 18↑61.5% | 11↑781.4% | 1 | |
| Income Before Tax | -52↑84.6% | -341↑47.7% | -651↑32.8% | -969↓21.8% | -796 | |
| Income Tax Expense | 2↓74.3% | 6↑146.4% | 2↑20.3% | 2↑120.8% | 0.90 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -54↑84.5% | -347↑47.0% | -654↑32.7% | -971↓21.9% | -797 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -54↑84.5% | -347↑47.0% | -654↑32.7% | -971↓21.9% | -797 | |
| Bottom-Line Net Income | -54↑84.5% | -347↑47.0% | -654↑32.7% | -971↓21.9% | -797 | |
| EPS (Basic) | -49.60↓47.3% | -33.67↑47.3% | -63.84↑31.7% | -93.47↓22.3% | -76.45 | |
| EPS (Diluted) | -49.60↓47.3% | -33.67↑47.3% | -63.84↑31.7% | -93.47↓22.3% | -76.45 | |
| Weighted Average Shares | 1↓89.5% | 10↑0.5% | 10↓1.5% | 10↓0.3% | 10 | |
| Weighted Average Diluted Shares | 1↓89.5% | 10↑0.5% | 10↓1.5% | 10↓0.3% | 10 | |
* All figures in Millions of CNY, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.